14 results on '"Tenneti, N"'
Search Results
2. Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines
- Author
-
Gordon, SF, Virah Sawmy, E, Duckworth, E, Wolthuizen, M, Clothier, HJ, Chea, M, Tenneti, N, Blow, N, Buttery, JP, de Luca, J, Korman, TM, Barnes, S, Slade, C, Maggs, C, Giles, ML, Teh, BW, Aboltins, C, Langan, KM, Van Diemen, A, Crawford, NW, Gordon, SF, Virah Sawmy, E, Duckworth, E, Wolthuizen, M, Clothier, HJ, Chea, M, Tenneti, N, Blow, N, Buttery, JP, de Luca, J, Korman, TM, Barnes, S, Slade, C, Maggs, C, Giles, ML, Teh, BW, Aboltins, C, Langan, KM, Van Diemen, A, and Crawford, NW
- Abstract
The Victorian Specialist Immunization Services (VicSIS) was established in Victoria, Australia, in February 2021, aiming to enhance vaccine safety services for Coronavirus disease (COVID-19) vaccines. VicSIS supports practitioners and patients with complex vaccine safety questions, including those who experience adverse events following immunization (AEFI) after COVID-19 vaccines. VicSIS provides individual vaccination recommendations, allergy testing, vaccine challenges, and vaccination under supervision. VicSIS initially comprised of eight adult COVID-19 specialist vaccination clinics, subsequently, expanding to better support pediatric patients as the Australian vaccine roll-out extended to adolescents and children. Since their establishment to September 2021, the inaugural VicSIS clinics received a total of 26,401 referrals and reviewed 6,079 patients. Consults were initially predominantly for pre-vaccination reviews, later predominantly becoming post-vaccination AEFI reviews as the program progressed. Regardless of the type of consult, the most common consult outcome was a recommendation for routine vaccination (73% and 55% of consult outcomes respectively). VicSIS is an integral component of the COVID-19 vaccination program and supports confidence in COVID-19 vaccine safety by providing consistent advice across the state. VicSIS aims to strengthen the health system through the pandemic, bolstering specialist immunization services beyond COVID-19 vaccines, including training the next generation of vaccinology experts.
- Published
- 2022
3. Non-communicable disease risk factors and care cascade management among internal migrant persons in China: systematic review and meta-analysis
- Author
-
Lee, TY, Qian, C, Zhao, Y, Anindya, K, Tenneti, N, Desloge, A, Atun, R, Qin, V, and Mulcahy, P
- Subjects
systematic review ,epidemiology - Abstract
Background In 2019, there are more than 290 million people who have ever migrated from rural to urban areas in China. These rural-to-urban internal migrants account for more than one-fifth of China’s population and is the largest internal migrant group globally. We present the first systematic review that examines whether internal migrants are more likely to exhibit non-communicable diseases (NCDs) risk factors and have worse NCD management outcomes than non-migrant counterparts in China. Methods A systematic review was conducted via medical, public health, and economic databases including Scopus, MEDLINE, JSTOR, WHO Library Database, and World Bank e-Library from 2000 to 2020. Study quality was assessed using the National Institute of Health Quality Assessment (NIH QA) tool. We conducted a narrative review and synthesised differences for all studies included, stratified by different types of outcomes. We also conducted random-effects meta-analysis where we had a minimum of two studies with 95% CIs reported. The study protocol has been registered with PROSPERO: CRD 42019139407. Results For most NCD risk factors and care cascade management, comparisons between internal migrants and other populations were either statistically insignificant or inconclusive. While most studies found migrants have a higher prevalence of tobacco use than urban residents, these differences were not statistically significant in the meta-analysis. Although three out four studies suggested that migrants may have worse access to NCD treatment and both studies suggested migrants have lower blood pressure control rates than non-migrants, these findings were not statistically significant. Conclusion Findings from this systematic review demonstrate that there is currently insufficient evidence on migrant and non-migrant differences in NCD risk factors and management in China. Further research is expected to investigate access to healthcare among internal and its effect on both their NCD outcomes and long-term healthcare costs in China.
- Published
- 2021
4. Population-based analysis of the epidemiological features of COVID-19 epidemics in Victoria, Australia, January 2020 - March 2021, and their suppression through comprehensive control strategies
- Author
-
Sullivan, SG, Brotherton, JML, Lynch, BM, Cheung, A, Lydeamore, M, Stevenson, M, Firestone, S, Canevari, J, Nguyen, HNJ, Carville, KS, Clothier, HJ, Goldsmith, J, Tenneti, N, Barnes, C, Tzimourtas, N, Gang, RF, Armstrong, J, Franklin, L, Hennessy, D, Martin, K, Baptista, M, Muleme, M, Osborne, A, Alpren, C, Ampt, FH, Castree, N, Hernandez, A, van Diemen, A, Cheng, AC, Crouch, S, Leeb, K, Matson, K, Romanes, F, Looker, C, Wong, E, Wallace, E, Sutton, B, Rowe, SL, Sullivan, SG, Brotherton, JML, Lynch, BM, Cheung, A, Lydeamore, M, Stevenson, M, Firestone, S, Canevari, J, Nguyen, HNJ, Carville, KS, Clothier, HJ, Goldsmith, J, Tenneti, N, Barnes, C, Tzimourtas, N, Gang, RF, Armstrong, J, Franklin, L, Hennessy, D, Martin, K, Baptista, M, Muleme, M, Osborne, A, Alpren, C, Ampt, FH, Castree, N, Hernandez, A, van Diemen, A, Cheng, AC, Crouch, S, Leeb, K, Matson, K, Romanes, F, Looker, C, Wong, E, Wallace, E, Sutton, B, and Rowe, SL
- Abstract
BACKGROUND: Victoria experienced the greatest burden of COVID-19 in Australia in 2020. This report describes key epidemiological characteristics and corresponding control measures between 17 January 2020 and 26 March 2021. METHODS: COVID-19 notifications made to the State Government Department of Health were used in this analysis. Epidemiological features are described over 4 phases, including enhancements to testing, contact tracing and public health interventions. Demographic and clinical features of cases are described. FINDINGS: Victoria recorded 20,483 cases of COVID-19, of which 1073 (5•2%) were acquired overseas and 19,360 (95%) were locally acquired. The initial epidemic (Phase I) was well-contained through public health interventions and was followed by relaxation of restrictions and low-level community transmission (Phase II). However, an outbreak in a hotel used to quarantine returned travellers led to wide-scale community transmission accounting for a majority (91%) of cases (Phase III). Outbreaks occurred in vulnerable settings including aged care and hospitals, contributing to high hospitalisation (12%) and case fatality rates (3•7%). Aggressive restrictions ultimately led to local elimination, and subsequent outbreaks have been swiftly managed with improved processes (Phase IV). The demographic composition of cases evolved across phases from an older, wealthier population to a less advantaged younger population, with many from culturally and linguistically diverse backgrounds. INTERPRETATION: Over time, adaptations to the public health response have strengthened capacity to respond to new cases and outbreaks in a more effective manner. The Victorian experience underscores the importance of authentic engagement with diverse communities and balancing restrictions with livelihoods.
- Published
- 2021
5. Non-communicable disease risk factors and management among internal migrant in China: systematic review and meta-analysis
- Author
-
Qian, CX, Zhao, Y, Anindya, K, Tenneti, N, Desloge, A, Atun, R, Qin, VM, Mulcahy, P, Lee, JT, Qian, CX, Zhao, Y, Anindya, K, Tenneti, N, Desloge, A, Atun, R, Qin, VM, Mulcahy, P, and Lee, JT
- Abstract
BACKGROUND: In 2019, there are more than 290 million people who have ever migrated from rural to urban areas in China. These rural-to-urban internal migrants account for more than one-fifth of China's population and is the largest internal migrant group globally. We present the first systematic review that examines whether internal migrants are more likely to exhibit non-communicable diseases (NCDs) risk factors and have worse NCD management outcomes than non-migrant counterparts in China. METHODS: A systematic review was conducted via medical, public health, and economic databases including Scopus, MEDLINE, JSTOR, WHO Library Database and World Bank e-Library from 2000 to 2020. Study quality was assessed using the National Institute of Health Quality Assessment tool. We conducted a narrative review and synthesised differences for all studies included, stratified by different types of outcomes. We also conducted random-effects meta-analysis where we had a minimum of two studies with 95% CIs reported. The study protocol has been registered with PROSPERO: CRD42019139407. RESULTS: For most NCD risk factors and care cascade management, comparisons between internal migrants and other populations were either statistically insignificant or inconclusive. While most studies found migrants have a higher prevalence of tobacco use than urban residents, these differences were not statistically significant in the meta-analysis. Although three out four studies suggested that migrants may have worse access to NCD treatment and both studies suggested migrants have lower blood pressure control rates than non-migrants, these findings were not statistically significant. CONCLUSION: Findings from this systematic review demonstrate that there is currently insufficient evidence on migrant and non-migrant differences in NCD risk factors and management in China. Further research is expected to investigate access to healthcare among internal and its effect on both their NCD outcomes and long
- Published
- 2021
6. The Joint Effect of Physical Multimorbidity and Mental Health Conditions Among Adults in Australia
- Author
-
Ishida, M, Hulse, ESG, Mahar, RK, Gunn, J, Atun, R, McPake, B, Tenneti, N, Anindya, K, Armstrong, G, Mulcahy, P, Carman, W, Lee, JT, Ishida, M, Hulse, ESG, Mahar, RK, Gunn, J, Atun, R, McPake, B, Tenneti, N, Anindya, K, Armstrong, G, Mulcahy, P, Carman, W, and Lee, JT
- Abstract
INTRODUCTION: The prevalence of chronic physical and mental health conditions is rising globally. Little evidence exists on the joint effect of physical and mental health conditions on health care use, work productivity, and health-related quality of life in Australia. METHODS: We analyzed data from the Household, Income and Labour Dynamics in Australia (HILDA) Survey, waves 9 (2009), 13 (2013), and 17 (2017). Economic effects associated with multimorbidity were measured through health service use, work productivity loss, and health-related quality of life. We used generalized estimating equations to assess the effect of the association between physical multimorbidity and mental health conditions and economic outcomes. RESULTS: From 2009 through 2017 the prevalence of physical multimorbidity increased from 15.1% to 16.2%, and the prevalence of mental health conditions increased from 11.2% to 17.3%. The number of physical health conditions was associated with the number of health services used (general practitioner visits, incidence rate ratio = 1.41), work productivity loss (labor force participation, adjusted odds ratio = 0.71), and reduced health-related quality of life (SF-6D score: Coefficient = -0.03). These effects were exacerbated by the presence of mental health conditions and low socioeconomic status. CONCLUSION: Having multiple physical health conditions (physical multimorbidity) creates substantial health and financial burdens on individuals, the health system, and society, including increased use of health services, loss of work productivity, and decreased health-related quality of life. The adverse effects of multimorbidity on health, quality of life, and economic well-being are exacerbated by the co-occurrence of mental health conditions and low socioeconomic status.
- Published
- 2020
7. Reframing the impact of business on health: the interface of corporate, commercial, political and social determinants of health
- Author
-
Rochford, C, Tenneti, N, Moodie, R, Rochford, C, Tenneti, N, and Moodie, R
- Published
- 2019
8. The Reemergence of Syphilis Among Females of Reproductive Age and Congenital Syphilis in Victoria, Australia, 2010 to 2020: A Public Health Priority.
- Author
-
Borg SA, Tenneti N, Lee A, Drewett GP, Ivan M, and Giles ML
- Subjects
- Pregnancy, Humans, Female, Victoria epidemiology, Public Health, Health Priorities, Syphilis epidemiology, Syphilis diagnosis, Syphilis, Congenital epidemiology, Syphilis, Congenital prevention & control
- Abstract
Background: Syphilis notifications in Victoria, Australia, have been increasing over the past decade, with an increase in infectious syphilis (syphilis of less than 2 years in duration) cases in females of reproductive age and an associated reemergence of congenital syphilis (CS). Before 2017, there had been 2 CS cases in the preceding 26 years. This study describes the epidemiology of infectious syphilis among females of reproductive age and CS in Victoria., Methods: Routine surveillance data provided by mandatory Victorian syphilis case notifications were extracted and grouped into a descriptive analysis of infectious syphilis and CS incidence data from 2010 to 2020., Results: In 2020, infectious syphilis notifications in Victoria were approximately 5 times more than 2010 (n = 289 in 2010 to n = 1440 in 2020), with a more than 7-fold rise among females (n = 25 in 2010 to n = 186 in 2020). Females made up 29% (n = 60 of 209) of Aboriginal and Torres Strait Islander notifications occurring between 2010 and 2020. Between 2017 and 2020, 67% of notifications in females (n = 456 of 678) were diagnosed in low-caseload clinics, at least 13% (n = 87 of 678) of all female notifications were known to be pregnant at diagnosis, and there were 9 CS notifications., Conclusions: Cases of infectious syphilis in females of reproductive age and CS are on the rise in Victoria, necessitating sustained public health action. Increasing awareness among individuals and clinicians, and health system strengthening, particularly targeting primary care where most females are diagnosed before pregnancy, are required. Treating infections before or promptly during pregnancy and undertaking partner notification and treatment to reduce risk of reinfection are critical to reducing CS cases., Competing Interests: Conflict of Interest and Sources of Funding: All authors declare no conflicts of interest. No funding was received for this research., (Copyright © 2023 American Sexually Transmitted Diseases Association. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
9. The role of hospitals in strengthening primary health care in the Western Pacific.
- Author
-
Freijser L, Annear P, Tenneti N, Gilbert K, Chukwujekwu O, Hazarika I, and Mahal A
- Abstract
Despite the imperative to strengthen primary health care (PHC) to respond to demographic and epistemological transitions, and meet commitments to achieve universal health coverage, health systems remain hospital-centric with health resources largely concentrated in urban centres. This paper examines islands of innovation that demonstrate the role hospitals can play in influencing the provision of PHC. Drawing on the literature and country case studies from the Western Pacific region, we illustrate mechanisms used to unlock hospital resources to improve PHC, with the transition towards "systems-focused hospitals". This paper identifies four "ideal types" of roles hospitals perform to strengthen PHC in different contexts. This provides a framework to inform health systems policy by examining existing and potential roles of hospitals to support the provision of frontline services and reorient health systems towards PHC., Competing Interests: Support for the project was limited to funding by WPRO for the original research. The authors have no other interests to declare., (© 2023 Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
10. Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines.
- Author
-
Gordon SF, Virah Sawmy E, Duckworth E, Wolthuizen M, Clothier HJ, Chea M, Tenneti N, Blow N, Buttery JP, de Luca J, Korman TM, Barnes S, Slade C, Maggs C, Giles ML, Teh BW, Aboltins C, Langan KM, Van Diemen A, and Crawford NW
- Subjects
- Adolescent, Adult, Adverse Drug Reaction Reporting Systems, COVID-19 Vaccines adverse effects, Child, Humans, Immunization adverse effects, Population Surveillance, Vaccination adverse effects, Victoria, COVID-19 prevention & control, Vaccines adverse effects
- Abstract
The Victorian Specialist Immunization Services (VicSIS) was established in Victoria, Australia, in February 2021, aiming to enhance vaccine safety services for Coronavirus disease (COVID-19) vaccines. VicSIS supports practitioners and patients with complex vaccine safety questions, including those who experience adverse events following immunization (AEFI) after COVID-19 vaccines. VicSIS provides individual vaccination recommendations, allergy testing, vaccine challenges, and vaccination under supervision. VicSIS initially comprised of eight adult COVID-19 specialist vaccination clinics, subsequently, expanding to better support pediatric patients as the Australian vaccine roll-out extended to adolescents and children. Since their establishment to September 2021, the inaugural VicSIS clinics received a total of 26,401 referrals and reviewed 6,079 patients. Consults were initially predominantly for pre-vaccination reviews, later predominantly becoming post-vaccination AEFI reviews as the program progressed. Regardless of the type of consult, the most common consult outcome was a recommendation for routine vaccination (73% and 55% of consult outcomes respectively). VicSIS is an integral component of the COVID-19 vaccination program and supports confidence in COVID-19 vaccine safety by providing consistent advice across the state. VicSIS aims to strengthen the health system through the pandemic, bolstering specialist immunization services beyond COVID-19 vaccines, including training the next generation of vaccinology experts.
- Published
- 2022
- Full Text
- View/download PDF
11. Non-communicable disease risk factors and management among internal migrant in China: systematic review and meta-analysis.
- Author
-
Qian CX, Zhao Y, Anindya K, Tenneti N, Desloge A, Atun R, Qin VM, Mulcahy P, and Lee JT
- Subjects
- China epidemiology, Humans, Risk Factors, Rural Population, Noncommunicable Diseases epidemiology, Noncommunicable Diseases therapy, Transients and Migrants
- Abstract
Background: In 2019, there are more than 290 million people who have ever migrated from rural to urban areas in China. These rural-to-urban internal migrants account for more than one-fifth of China's population and is the largest internal migrant group globally. We present the first systematic review that examines whether internal migrants are more likely to exhibit non-communicable diseases (NCDs) risk factors and have worse NCD management outcomes than non-migrant counterparts in China., Methods: A systematic review was conducted via medical, public health, and economic databases including Scopus, MEDLINE, JSTOR, WHO Library Database and World Bank e-Library from 2000 to 2020. Study quality was assessed using the National Institute of Health Quality Assessment tool. We conducted a narrative review and synthesised differences for all studies included, stratified by different types of outcomes. We also conducted random-effects meta-analysis where we had a minimum of two studies with 95% CIs reported. The study protocol has been registered with PROSPERO: CRD42019139407., Results: For most NCD risk factors and care cascade management, comparisons between internal migrants and other populations were either statistically insignificant or inconclusive. While most studies found migrants have a higher prevalence of tobacco use than urban residents, these differences were not statistically significant in the meta-analysis. Although three out four studies suggested that migrants may have worse access to NCD treatment and both studies suggested migrants have lower blood pressure control rates than non-migrants, these findings were not statistically significant., Conclusion: Findings from this systematic review demonstrate that there is currently insufficient evidence on migrant and non-migrant differences in NCD risk factors and management in China. Further research is expected to investigate access to healthcare among internal and its effect on both their NCD outcomes and long-term healthcare costs in China., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
12. The Joint Effect of Physical Multimorbidity and Mental Health Conditions Among Adults in Australia.
- Author
-
Ishida M, Hulse ES, Mahar RK, Gunn J, Atun R, McPake B, Tenneti N, Anindya K, Armstrong G, Mulcahy P, Carman W, and Lee JT
- Subjects
- Adult, Chronic Disease, Humans, Mental Health, Prevalence, Quality of Life, Mental Disorders epidemiology, Multimorbidity
- Abstract
Introduction: The prevalence of chronic physical and mental health conditions is rising globally. Little evidence exists on the joint effect of physical and mental health conditions on health care use, work productivity, and health-related quality of life in Australia., Methods: We analyzed data from the Household, Income and Labour Dynamics in Australia (HILDA) Survey, waves 9 (2009), 13 (2013), and 17 (2017). Economic effects associated with multimorbidity were measured through health service use, work productivity loss, and health-related quality of life. We used generalized estimating equations to assess the effect of the association between physical multimorbidity and mental health conditions and economic outcomes., Results: From 2009 through 2017 the prevalence of physical multimorbidity increased from 15.1% to 16.2%, and the prevalence of mental health conditions increased from 11.2% to 17.3%. The number of physical health conditions was associated with the number of health services used (general practitioner visits, incidence rate ratio = 1.41), work productivity loss (labor force participation, adjusted odds ratio = 0.71), and reduced health-related quality of life (SF-6D score: Coefficient = -0.03). These effects were exacerbated by the presence of mental health conditions and low socioeconomic status., Conclusion: Having multiple physical health conditions (physical multimorbidity) creates substantial health and financial burdens on individuals, the health system, and society, including increased use of health services, loss of work productivity, and decreased health-related quality of life. The adverse effects of multimorbidity on health, quality of life, and economic well-being are exacerbated by the co-occurrence of mental health conditions and low socioeconomic status.
- Published
- 2020
- Full Text
- View/download PDF
13. Reframing the impact of business on health: the interface of corporate, commercial, political and social determinants of health.
- Author
-
Rochford C, Tenneti N, and Moodie R
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2019
- Full Text
- View/download PDF
14. Concentrations of leptin, adiponectin and other metabolic parameters in non-obese children with Down syndrome.
- Author
-
Tenneti N, Dayal D, Sharda S, Panigrahi I, Didi M, Attri SV, Sachdeva N, and Bhalla AK
- Subjects
- Body Mass Index, Cardiovascular Diseases etiology, Case-Control Studies, Child, Child, Preschool, Cross-Sectional Studies, Down Syndrome complications, Female, Humans, Insulin Resistance, Male, Risk Factors, Adiponectin blood, Blood Glucose metabolism, Cardiovascular Diseases blood, Down Syndrome blood, Leptin blood
- Abstract
Background: Recent data indicates that adults with Down syndrome (DS) are at increased risk for cardiovascular disease (CVD) that significantly contributes to their morbidity and mortality. Although identification of cardiometabolic risk factors during childhood is desirable to design preventive interventions, the data on such risk factors in children with DS is scarce. The aim of this study was to study the cardiometabolic risk factors such as insulin resistance (IR), leptin and adiponectin concentrations, lipid abnormalities and leptin resistance in non-obese children with DS., Methods: This cross-sectional case control study included karyotype confirmed trisomy-21 DS children aged 2-12 years and their matched healthy controls. After detailed anthropometry, weight, height and body mass index (BMI) standard deviation scores (SDSs) were calculated with reference data. Laboratory evaluation included determination of fasting lipid parameters, insulin, glucose, leptin and adiponectin concentrations. The homeostasis model assessment method (HOMA-IR) was used to assess IR and the ratio of leptin to BMI was used as an index of leptin resistance., Results: Seventy-seven children (39 with DS and 38 controls) comprised the study cohort. The anthropometric parameters were similar in the two groups. Children with DS showed significantly higher mean leptin concentrations (2.098±1.68 ng/mL vs. 1.44±0.52 ng/mL, p-value: 0.00) and higher indices of leptin resistance (0.127±0.085 vs. 0.09±0.03, p-value: 0.001) as compared to controls. Fasting adiponectin concentrations were lower (20.64±19.87 ng/mL vs. 32.58±34.25 ng/mL, p-value: 0.21) and fasting glucose higher (89.25±8.12 mg/dL vs. 85.71±5.52 mg/dL, p-value: 0.06) in the DS group as compared to the controls but the differences did not reach statistical significance. The concentrations of insulin, various lipid parameters and calculated HOMA-IR values were similar in the two groups. In the DS group, five children were identified to have high (>75th centile) leptin levels and four as impaired fasting glucose as compared to none in the controls., Conclusions: Alterations of several cardiometabolic risk factors, in particular, leptin concentrations and leptin resistance are present in children with DS. The presence of hyperleptinemia without hyperinsulinemia suggests a probable inherent genetic basis for increased leptin resistance in patients with DS. There is a need for larger studies to further understand increased leptin resistance in DS that may contribute to increased CVD related morbidity and mortality in these patients.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.